Iodine (I-131)
Treatment:
Potassium iodide (FDA approved for this indication)
For NCRP suggestions, see REMM online
http://www.remm.nlm.gov/int_contamination.htm
Ionizing radiation decay mode:
β, γ
Radioactive half-life:
8.1 days
Biological half-life:
138 days
Major exposure pathways:
Inhalation
Ingestion
Skin
Focal accumulation:
Thyroid